Valerio Therapeutics announces acquisition of Emglev Therapeutics
Valerio Therapeutics, a developer of DNA Decoy therapeutics, has announced its acquisition of Emglev Therapeutics, a company specialising in single-domain antibody-based therapeutics. This strategic m...